Relevant Market Insights India’s biopharmaceutical sector is at a pivotal point in its evolution. Long celebrated as the world’s “pharmacy of the world” for generics and vaccines, the broader bi...
Key Highlights: Implications: Emcure’s move to take Gennova to 100% ownership and fold it under the “One Emcure” framework tightens control over a strategically important biologi...
Latest Developments in Specialty Pharma India’s pharmaceutical industry has built a global reputation as a leading supplier of affordable generic medicines. Over the past two decades, Indian com...
Key Highlights: Implications: This partnership accelerates peptide therapy access in high-growth markets, challenging incumbents like Sun Pharma in India’s $500M+ peptide segment whi...
Key Highlights: Implications: Tishtha detonates pricing bombs on Roche’s Tecentriq and MSD’s Opdivo, handing cash-strapped hospitals a lifeline while exploding p...
Relevant Industry Developments India’s biopharmaceutical sector is no longer defined solely by its global dominance in generics. Over the past decade, biologics and biosimilars have emerged as o...
Latest Developments in Peptide-Based Medicines Peptide-based drugs are gaining significant attention in the global pharmaceutical industry due to their ability to target specific biological path...
Key Highlights: Implications: The large-scale Daisy Petal deployment at Serum Institute signals a meaningful shift from traditional fed-batch to perfusion-based biomanufacturing in v...
